Holen Sie sich die Stockscreener-App
4.68
3.90%
-0.19
Handel nachbörslich:
4.75
0.07
+1.50%
Finanzdaten der Cytomx Therapeutics Inc-Aktie (CTMX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
68.04%
5.963
|
18.66 | 50.92 | 25.11 | 33.43 |
Operating Expenses
|
8.96%
21.73
|
19.94 | 28.30 | 33.57 | 29.32 |
| Benefits Costs and Expenses |
7.39%
20.13
|
18.75 | 27.33 | 31.60 | 27.64 |
| Costs And Expenses |
7.39%
20.13
|
18.75 | 27.33 | 31.60 | 27.64 |
| Operating Income/Loss |
1,126%
-15.77
|
-1.286 | 22.62 | -8.452 | 4.111 |
| Income/Loss From Continuing Operations Before Tax |
15,473%
-14.17
|
-0.091 | 23.59 | -6.483 | 5.797 |
| Income Tax Expense/Benefit |
7.94%
0.058
|
0.063 | 0.062 | 0.051 | 0.061 |
| Income/Loss From Continuing Operations After Tax |
9,140%
-14.23
|
-0.154 | 23.52 | -6.534 | 5.736 |
|
Net Income/Loss
|
9,140%
-14.23
|
-0.154 | 23.52 | -6.534 | 5.736 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
27.84%
165.00
|
129.08 | 87.12 | 84.88 | 85.09 |
| Diluted Average Shares |
27.84%
165.00
|
129.08 | 87.15 | 84.88 | 85.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):